Ovid Therapeutics (OVID) Return on Capital Employed Growth (3y) (2020 - 2026)
Ovid Therapeutics (OVID) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 4,853.00 |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - | 1,032.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,032.00 |
| Dec 31, 2025 | -655.00 |
| Dec 31, 2024 | -13,799.00 |
| Sep 30, 2024 | -13,393.00 |
| Jun 30, 2024 | -11,895.00 |
| Mar 31, 2024 | -13,018.00 |
| Dec 31, 2023 | 8,381.00 |
| Sep 30, 2023 | 10,896.00 |
| Jun 30, 2023 | 15,720.00 |
| Mar 31, 2023 | 7,238.00 |
| Dec 31, 2022 | 8,597.00 |
| Dec 31, 2021 | 18,396.00 |
| Sep 30, 2021 | 15,775.00 |
| Jun 30, 2021 | 12,861.00 |
| Mar 31, 2021 | 13,925.00 |
| Dec 31, 2020 | -5,768.00 |
| Sep 30, 2020 | -8,994.00 |
| Jun 30, 2020 | -11,672.00 |
| Mar 31, 2020 | 694.00 |